US2011059026A1PendingUtilityA1

Pharmaceutical dosage form bearing pregnancy-friendly indicia

Assignee: DUCHESNAY INCPriority: Jul 5, 2002Filed: Nov 12, 2010Published: Mar 10, 2011
Est. expiryJul 5, 2022(expired)· nominal 20-yr term from priority
A61K 31/4402A61K 31/4415A61K 45/06A61K 31/44A61K 9/2072
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.

Claims

exact text as granted — not AI-modified
1 . A patient dosage regimen compliance improving pharmaceutical dosage form destined for administration to pregnant women, said pharmaceutical dosage form containing one or more vitamin supplement or drug, said pharmaceutical dosage form further comprising a graphical representation of a pregnant woman applied to the outer surface of the dosage form, said graphical representation being visible to the naked eye. 
     
     
         2 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 1  wherein the dosage form is a tablet. 
     
     
         3 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 1  wherein said pharmaceutical dosage form contains a vitamin supplement. 
     
     
         4 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 3  wherein the dosage form is a tablet. 
     
     
         5 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 3  wherein said vitamin supplement comprises folic acid. 
     
     
         6 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 5  wherein the dosage form is a tablet. 
     
     
         7 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 1 , wherein the vitamin supplement comprises vitamins or minerals. 
     
     
         8 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 1  wherein said pharmaceutical dosage form consists of a vitamin supplement. 
     
     
         9 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 8  wherein the dosage form is a tablet. 
     
     
         10 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 8  wherein said vitamin supplement comprises folic acid. 
     
     
         11 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 10  wherein the dosage form is a tablet. 
     
     
         12 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 1  wherein the graphical representation being visible to the naked eye is that shown in  FIG. 1 . 
     
     
         13 . The patient dosage regimen compliance improving pharmaceutical dosage form in accordance with  claim 12  wherein the dosage form is a tablet.

Join the waitlist — get patent alerts

Track US2011059026A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.